We have previously shown that human squamous cell carcinomas (SCC) express the
interleukin 2 receptor (IL2R)‐α and‐β chains, and that the ligand, IL2, directly inhibits growth …

Several human head and neck squamous carcinoma cell lines were found to bind 125I-
labeled or fluorescein-labeled interleukin 2 (IL-2). This binding was inhibited by an excess of …

Frozen sections of 52 human solid tumours (38 malignant and 14 benign) of varied
histogenesis were immunohistochemically stained with well characterised monoclonal …

It has been previously demonstrated that human carcinomas express interleukin‐2 receptor
(IL‐2R) α, β, and γ chains. The β and γ chains of IL‐2R have intermediate binding affinity for …

The expression of the interleukin 4 (IL-4) receptor (IL-4R) and effects of human recombinant
IL-4 on human gastric carcinoma cell lines were studied. We demonstrated that IL-4 …

The growth‐inhibitory effect of interleukin‐4 (IL‐4) was investigated in a panel of 7 human
colorectal‐carcinoma cell lines. In 5 cell lines (HT29, WiDr, LS41 IN, LS513, LS1034) a …

Abstract Interleukin‐1 receptor antagonist (IL‐1Ra) is an endogenous inhibitor of interleukin‐
1. The expression of IL‐1Ra and interleukin‐1α (IL‐1α) was measured in murine epidermis …

We have previously reported on the expression of interleukin-4 receptor (IL-4R) on many
solid cancer cell lines. In the present study, we have examined the expression of IL-4R on …

Abstract Interleukin (IL-2) and IL-2Rβ/γ have been shown to be expressed in human
carcinomas in culture and in situ. Recently, expression of endogenous IL-2 and IL-2R in the …

Abstract Interleukin 1 (IL‐1) is a major mediator of inflammation and exerts pleiotropic effects
on many systems. To elucidate the role of its endogenous inhibitor, intracellular IL‐1 …